Related Experiment Video
Updated: Jul 2, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Rheumatoid meningitis: A systematic review and meta-analysis
Eduardo Villa1, Teresita Sarquis1, José de Grazia2
1Department of Neurology and Neurosurgery, Faculty of Medicine, Hospital Clínico Universidad de Chile, Santiago, Chile.
Background And Purpose:
Rheumatoid meningitis (RM) is a neurological complication of rheumatoid arthritis (RA). Current evidence is based on case reports and partial reviews.
Methods:
This is a systematic review and meta-analysis following the PRISMA statement. The aim is to describe the characteristics of the disease, including clinical, imaging and laboratory findings, treatment, outcomes and prognosis reported in the literature.
Results:
In all, 103 studies with 130 cases were included. RM affected adults with an average age of 62 years, with or without a previous RA diagnosis. RA activity and time with the disease were associated with a worse prognosis. Most common clinical manifestations were transient focal neurological signs (64.6%), systemic symptoms (51.3%), episodic headache (50.4%) and neuropsychiatric alterations (47.7%). Joint manifestations were present in only 27.4% of cases. Brain magnetic resonance imaging showed unilateral or bilateral involvement, predominantly frontoparietal. Both pachymeninges and leptomeninges were affected, the latter more frequently (82.88%). The laboratory findings included increased levels of rheumatoid factor (89.71%), anti-cyclic citrullinated peptide (89.47%), C-reactive protein (82.54%) and erythrocyte sedimentation rate (81.81%). Cerebrospinal fluid analysis showed an increase in the protein level (76.14%), with pleocytosis (85.19%) of mononuclear predominance (89.19%). Biopsy was performed in 72.52% of the patients. Corticosteroid pulse therapy was the main induction therapy. Disease relapse occurred in 31.17% of patients, whilst 54.54% had a full recovery.
Conclusions:
Rheumatoid meningitis must be considered in adult patients with or without RA diagnosis, high-dose corticosteroid induction therapy should be installed and maintenance therapy plays a key role. It is not recommended to use anti-TNF as an induction therapy. Nowadays, RM has a significantly better outcome. These findings may aid clinicians in timely RM diagnosis and treatment, thus improving its outcomes.
Insights
Rheumatoid meningitis (RM), a complication of rheumatoid arthritis (RA), presents with neurological symptoms. Early diagnosis and high-dose corticosteroid treatment improve outcomes, with a significant recovery rate observed in this systematic review.
Area of Science:
- Neurology
- Rheumatology
- Systematic Review
Background:
- Rheumatoid meningitis (RM) is a rare neurological complication of rheumatoid arthritis (RA).
- Existing evidence is limited to case reports and partial reviews, necessitating a comprehensive analysis.
Purpose of the Study:
- To systematically review and analyze the characteristics of rheumatoid meningitis.
- To describe clinical, imaging, laboratory findings, treatments, and outcomes of RM.
Main Methods:
- Systematic review and meta-analysis adhering to the PRISMA statement.
- Inclusion of 103 studies comprising 130 cases of rheumatoid meningitis.
Main Results:
- RM affects adults (average age 62) with or without prior RA diagnosis; RA activity and disease duration correlate with poorer prognosis.
- Common symptoms include focal neurological signs (64.6%), systemic symptoms (51.3%), headache (50.4%), and neuropsychiatric changes (47.7%). Joint manifestations were infrequent (27.4%).
- Elevated rheumatoid factor, anti-CCP antibodies, CRP, and ESR were common laboratory findings. CSF analysis revealed increased protein and pleocytosis. Corticosteroid pulse therapy was the primary induction treatment, with a 31.17% relapse rate and 54.54% full recovery.
Conclusions:
- Rheumatoid meningitis should be suspected in adults, with or without RA diagnosis.
- High-dose corticosteroid induction therapy is crucial; maintenance therapy is key. Anti-TNF agents are not recommended for induction.
- Timely diagnosis and treatment, particularly with corticosteroids, significantly improve RM outcomes.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management
Bacterial Meningitis
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology